Clinical Trial Update: Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 study evaluating the Gemcitabine/Cisplatin/S-1 combination in advanced biliary tract cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Kansai Hepatobiliary Oncology Group | Conditions: Biliary Tract Cancer | Phase 1, Phase 2 | Status: COMPLETED